# A First-in-Human Study of LY3009385 in Healthy Participants

> **NCT01477567** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 40 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** LY3009385
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01477567
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01477567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01477567, "A First-in-Human Study of LY3009385 in Healthy Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01477567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*